Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3.

S J Allen Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

Search for other papers by S J Allen in
Current site
Google Scholar
PubMed
Close
,
A O'Donnell Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

Search for other papers by A O'Donnell in
Current site
Google Scholar
PubMed
Close
,
N D Alexander Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

Search for other papers by N D Alexander in
Current site
Google Scholar
PubMed
Close
,
C S Mgone Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

Search for other papers by C S Mgone in
Current site
Google Scholar
PubMed
Close
,
T E Peto Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

Search for other papers by T E Peto in
Current site
Google Scholar
PubMed
Close
,
J B Clegg Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

Search for other papers by J B Clegg in
Current site
Google Scholar
PubMed
Close
,
M P Alpers Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

Search for other papers by M P Alpers in
Current site
Google Scholar
PubMed
Close
, and
D J Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

Search for other papers by D J Weatherall in
Current site
Google Scholar
PubMed
Close
Restricted access

Southeast Asian ovalocytosis (SAO) occurs at high frequency in malarious regions of the western Pacific and may afford a survival advantage against malaria. It is caused by a deletion of the erythrocyte membrane band 3 gene and the band 3 protein mediates the cytoadherence of parasitized erythrocytes in vitro. The SAO band 3 variant may prevent cerebral malaria but it exacerbates malaria anemia and may also increase acidosis, a major determinant of mortality in malaria. We undertook a case-control study of children admitted to hospital in a malarious region of Papua New Guinea. The SAO band 3, detected by the polymerase chain reaction, was present in 0 of 68 children with cerebral malaria compared with six (8.8%) of 68 matched community controls (odds ratio = 0, 95% confidence interval = 0-0.85). Median hemoglobin levels were 1.2 g/dl lower in malaria cases with SAO than in controls (P = 0.035) but acidosis was not affected. The remarkable protection that SAO band 3 affords against cerebral malaria may offer a valuable approach to a better understanding of the mechanisms of adherence of parasitized erythrocytes to vascular endothelium, and thus of the pathogenesis of cerebral malaria.

Author Notes

Past two years Past Year Past 30 Days
Abstract Views 1274 972 46
Full Text Views 297 25 4
PDF Downloads 95 0 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save